Concourse Financial Group Securities’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-497
| Closed | -$179K | – | 891 |
|
2024
Q4 | $179K | Sell |
497
-42
| -8% | -$15.1K | 0.01% | 763 |
|
2024
Q3 | $180K | Buy |
539
+2
| +0.4% | +$669 | 0.01% | 748 |
|
2024
Q2 | $147K | Buy |
537
+84
| +19% | +$22.9K | 0.01% | 807 |
|
2024
Q1 | $157K | Buy |
453
+46
| +11% | +$15.9K | 0.01% | 765 |
|
2023
Q4 | $131K | Sell |
407
-9
| -2% | -$2.91K | 0.01% | 805 |
|
2023
Q3 | $149K | Buy |
416
+65
| +19% | +$23.3K | 0.01% | 715 |
|
2023
Q2 | $133K | Buy |
351
+39
| +13% | +$14.8K | 0.01% | 770 |
|
2023
Q1 | $149K | Sell |
312
-13
| -4% | -$6.23K | 0.01% | 736 |
|
2022
Q4 | $137K | Buy |
325
+7
| +2% | +$2.94K | 0.01% | 730 |
|
2022
Q3 | $133K | Sell |
318
-1
| -0.3% | -$418 | 0.01% | 639 |
|
2022
Q2 | $158K | Buy |
319
+1
| +0.3% | +$495 | 0.01% | 657 |
|
2022
Q1 | $179K | Sell |
318
-20
| -6% | -$11.3K | 0.01% | 665 |
|
2021
Q4 | $255K | Buy |
338
+41
| +14% | +$30.9K | 0.01% | 648 |
|
2021
Q3 | $222K | Sell |
297
-15
| -5% | -$11.2K | 0.01% | 685 |
|
2021
Q2 | $201K | Sell |
312
-9
| -3% | -$5.8K | 0.01% | 714 |
|
2021
Q1 | $183K | Sell |
321
-42
| -12% | -$23.9K | 0.01% | 712 |
|
2020
Q4 | $212K | Sell |
363
-19
| -5% | -$11.1K | 0.02% | 614 |
|
2020
Q3 | $197K | Buy |
382
+47
| +14% | +$24.2K | 0.02% | 551 |
|
2020
Q2 | $151K | Sell |
335
-5
| -1% | -$2.25K | 0.01% | 587 |
|
2020
Q1 | $119K | Buy |
+340
| New | +$119K | 0.01% | 601 |
|
2019
Q4 | – | Hold |
0
| – | – | – | 2482 |
|
2019
Q3 | – | Hold |
0
| – | – | – | 2181 |
|
2019
Q2 | – | Sell |
-48
| Closed | -$14K | – | 2587 |
|
2019
Q1 | $14K | Sell |
48
-119
| -71% | -$34.7K | ﹤0.01% | 1384 |
|
2018
Q4 | $38K | Sell |
167
-21
| -11% | -$4.78K | ﹤0.01% | 906 |
|
2018
Q3 | $59K | Buy |
+188
| New | +$59K | 0.02% | 552 |
|